4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001209191-16-093830
$TVRDCIK 0001346830operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:10 PM ET
Size
4.8 KB
Accession
0001209191-16-093830
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2016-01-26$10.93/sh−7,262$79,374→ 314,988 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2015.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 5:10 PM ET
- Size
- 4.8 KB